Innocare Announces BCL2 Inhibitor & Orelabrutinib for CLL/SLL
InnoCare Pharma received approval from China’s CDE to begin a Phase III trial of its BCL2 inhibitor, ICP-248 (Mesutoclax),...
Jon Napitupulu
GSK’s PENMENVY Vaccine Approved by US FDA
The FDA approved GSK’s PENMENVY, a combination vaccine against five serogroups of meningococcal disease (A, B, C, W, and...
Revolutionary New Prostate Cancer Super Test Developed in UK
Scientists in Cambridge developed a new prostate cancer test designed to revolutionize screening, diagnosis, and personalized treatment. The test...
Lacutamab Gets FDA Breakthrough Therapy for Sézary Syndrome
Innate Pharma received Breakthrough Therapy Designation from the FDA for lacutamab, its anti-KIR3DL2 antibody, for treating relapsed or refractory...
Carmat Aeson® Artificial Heart Shows Promise for Pulmonary Hypertension Patients
A single-center study at the University Medical Center of Astana, Kazakhstan, demonstrated the effectiveness of the Aeson® total artificial...
Dupixent® FDA Priority Review for Bullous Pemphigoid Treatment
Regeneron and Sanofi announced that the FDA accepted for Priority Review their supplemental Biologics License Application for Dupixent (dupilumab)...
EU Approves First Self-Amplifying mRNA COVID-19 Vaccine
CSL and Arcturus Therapeutics announced that the European Commission has approved KOSTAIVE (ARCT-154), a self-amplifying mRNA COVID-19 vaccine, for...
ORYZON Announces Journal Publication of Final Phase IIa REimagine Results with Vafidemstat
Oryzon Genomics announced the publication of final Phase IIa REIMAGINE study results, demonstrating the safety and efficacy of vafidemstat...
Benitec Biopharma’s BB-301 Study at MDA Conference
Benitec Biopharma announced interim clinical study updates for the first three subjects in its Phase 1b/2a trial of BB-301,...
Next-Gen Nectin-4 Targeting ADC Shows Promise in Phase 1 Study
Corbus Pharmaceuticals announced positive data from its US and UK Phase 1 dose escalation study of CRB-701, a next-generation...